Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat p75 NGF Receptor ELISA Kit (AC3385)
Cat.#: ASET-1974
Specifications
Description Rat p75 NGF Receptor ELISA Kit allows for the in vitro quantitative determination of rat p75 NGF Receptor concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1526 Rat CGRP ELISA Kit (AC2937) Quantitative inquiry ASET-1003 Porcine GLP1 ELISA Kit (AC2414) Quantitative inquiry ASET-1832 Human NCAM1 ELISA Kit (AC3243) Quantitative inquiry ASET-1608 Mouse LRP5 ELISA Kit (AC3019) Quantitative inquiry ASET-2362 Mouse GJB2 ELISA Kit (AC3773) Quantitative inquiry ASET-2067 Rat GMFB ELISA Kit (AC3478) Quantitative inquiry ASET-1288 Human Somatostatin Receptor 2 ELISA Kit (AC2699) Quantitative inquiry ASET-1375 Human KIAA1199 ELISA Kit (AC2786) Quantitative inquiry ASET-2330 Human POMC ELISA Kit (AC3741) Quantitative inquiry ASET-1361 Sheep Inhibin beta B ELISA Kit (AC2772) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket